CNS Pharmaceuticals
CNSP
CNSP
13 hedge funds and large institutions have $75.3K invested in CNS Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 3 closing their positions.
Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
3
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$26.5K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$23.8K |
| 3 |
VF
3
Virtu Financial
New York
|
$16K |
| 4 |
4
Goldman Sachs
New York
|
$3.68K |
| 5 |
5
Jane Street
New York
|
$3.02K |
Top Sellers
| 1 |
AFM
1
Anson Funds Management
Dallas,
Texas
|
$0 |
| 2 |
2
Morgan Stanley
New York
|
$0 |
| 3 |
3
Fidelity Investments
Boston,
Massachusetts
|
$0 |
